BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 2246865)

  • 1. Putative genetic deficiency of 4-hydroxyphenylpyruvic acid dioxygenase in mice: a murine model for hereditary tyrosinaemia type III.
    Endo F; Katoh H; Matsuda I
    J Inherit Metab Dis; 1990; 13(5):780-2. PubMed ID: 2246865
    [No Abstract]   [Full Text] [Related]  

  • 2. A nonsense mutation in the 4-hydroxyphenylpyruvic acid dioxygenase gene (Hpd) causes skipping of the constitutive exon and hypertyrosinemia in mouse strain III.
    Endo F; Awata H; Katoh H; Matsuda I
    Genomics; 1995 Jan; 25(1):164-9. PubMed ID: 7774914
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A new variant form of hypertyrosinaemia due to 4-hydroxyphenylpyruvic acid oxidase deficiency.
    Endo F; Kitano A; Uehara I; Nagata N; Matsuda I; Shinka T; Kuhara T; Matsumoto I
    J Inherit Metab Dis; 1982; 5(4):237-8. PubMed ID: 6133038
    [No Abstract]   [Full Text] [Related]  

  • 4. Tyrosinaemia type III: immunochemical studies on 4-hydroxyphenylpyruvic acid dioxygenase and molecular cloning of cDNA for the enzyme.
    Endo F; Awata H; Tanoue A; Eda Y; Matsuda I
    J Inherit Metab Dis; 1991; 14(5):783-6. PubMed ID: 1779624
    [No Abstract]   [Full Text] [Related]  

  • 5. [Hereditary tyrosinemia type III].
    Endo F
    Ryoikibetsu Shokogun Shirizu; 1998; (18 Pt 1):137-40. PubMed ID: 9590008
    [No Abstract]   [Full Text] [Related]  

  • 6. Autoimmune thyroiditis in a case of tyrosinaemia type III.
    D'Eufemia P; Giardini O; Cantani A; Martino F; Finocchiaro R
    J Inherit Metab Dis; 1992; 15(6):861-2. PubMed ID: 1293381
    [No Abstract]   [Full Text] [Related]  

  • 7. Hepatic tyrosine aminotransferase in tyrosinaemia type II.
    Kida K; Takahashi M; Fujisawa Y; Matsuda H; Machino H; Miki Y
    J Inherit Metab Dis; 1982; 5(4):229-30. PubMed ID: 6133036
    [No Abstract]   [Full Text] [Related]  

  • 8. A murine model for type III tyrosinemia: lack of immunologically detectable 4-hydroxyphenylpyruvic acid dioxygenase enzyme protein in a novel mouse strain with hypertyrosinemia.
    Endo F; Katoh H; Yamamoto S; Matsuda I
    Am J Hum Genet; 1991 Apr; 48(4):704-9. PubMed ID: 2014797
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tyrosinemia type III: diagnosis and ten-year follow-up.
    Cerone R; Holme E; Schiaffino MC; Caruso U; Maritano L; Romano C
    Acta Paediatr; 1997 Sep; 86(9):1013-5. PubMed ID: 9343288
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure of the human 4-hydroxyphenylpyruvic acid dioxygenase gene (HPD).
    Awata H; Endo F; Matsuda I
    Genomics; 1994 Oct; 23(3):534-9. PubMed ID: 7851880
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunological abnormalities in a patient with tyrosinaemia type III.
    D'Eufemia PD; Finocchiaro R; Celli M; Viozzi L; Giardini O
    J Inherit Metab Dis; 1995; 18(3):355-6. PubMed ID: 7474904
    [No Abstract]   [Full Text] [Related]  

  • 12. Four-hydroxyphenylpyruvic acid oxidase deficiency with normal fumarylacetoacetase: a new variant form of hereditary hypertyrosinemia.
    Endo F; Kitano A; Uehara I; Nagata N; Matsuda I; Shinka T; Kuhara T; Matsumoto I
    Pediatr Res; 1983 Feb; 17(2):92-6. PubMed ID: 6828337
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New treatment for tyrosinaemia.
    Lancet; 1992 Oct; 340(8823):822-3. PubMed ID: 1357248
    [No Abstract]   [Full Text] [Related]  

  • 14. Tyrosinosis (tyrosinaemia).
    Jaiswal RB
    Indian Pediatr; 1975 Mar; 12(3):209-10. PubMed ID: 239906
    [No Abstract]   [Full Text] [Related]  

  • 15. In vivo correction with recombinant adenovirus of 4-hydroxyphenylpyruvic acid dioxygenase deficiencies in strain III mice.
    Kubo S; Kiwaki K; Awata H; Katoh H; Kanegae Y; Saito I; Yamamoto T; Miyazaki J; Matsuda I; Endo F
    Hum Gene Ther; 1997 Jan; 8(1):65-71. PubMed ID: 8989996
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutations in the 4-hydroxyphenylpyruvic acid dioxygenase gene are responsible for tyrosinemia type III and hawkinsinuria.
    Tomoeda K; Awata H; Matsuura T; Matsuda I; Ploechl E; Milovac T; Boneh A; Scott CR; Danks DM; Endo F
    Mol Genet Metab; 2000 Nov; 71(3):506-10. PubMed ID: 11073718
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of hereditary tyrosinaemia type I by inhibition of 4-hydroxyphenylpyruvate dioxygenase.
    Lindstedt S; Holme E; Lock EA; Hjalmarson O; Strandvik B
    Lancet; 1992 Oct; 340(8823):813-7. PubMed ID: 1383656
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Hereditary tyrosinemia: examination of the liver by electron microscopy of hepatic biopsies: observation of 7 cases].
    Tremblay M; Bélanger L; Larochelle J; Privé L; Gagnon PM
    Union Med Can; 1977 Jul; 106(7):1014-6. PubMed ID: 898402
    [No Abstract]   [Full Text] [Related]  

  • 19. [Association, in the same subject, of deletion of the short arm of chromosome 4 (4p-) and of complete deficiency of parahydroxyphenyl-pyruvate oxidase activity in the liver (tyrosinosis)].
    Malpuech G; Mattei JF; Gaulme J; Palcoux JB; Lesec G; Vanlieferinghen P
    J Genet Hum; 1981 Dec; 29(4):455-61. PubMed ID: 7328420
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Other abnormalities of tyrosine metabolism].
    Endo F
    Ryoikibetsu Shokogun Shirizu; 1998; (18 Pt 1):144-5. PubMed ID: 9590010
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.